<div id="readability-page-1"><p>Tompkins Financial Corp decreased its holdings in shares of  Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 74.1% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 1,966 shares of the semiconductor company's stock after selling 5,634 shares during the period. Tompkins Financial Corp's holdings in Synopsys were worth $970,000 at the end of the most recent quarter.</p><ul><li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li></ul><p>Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Saudi Central Bank purchased a new stake in  Synopsys during the 1st quarter worth approximately $26,000.  Independence Bank of Kentucky lifted its stake in shares of  Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company's stock worth $28,000 after buying an additional 30 shares during the period.  Princeton Global Asset Management LLC grew its holdings in shares of  Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company's stock valued at $33,000 after buying an additional 53 shares during the last quarter.  WPG Advisers LLC acquired a new position in shares of  Synopsys in the 1st quarter valued at $34,000.  Finally, AlphaQuest LLC raised its stake in  Synopsys by 423.1% in the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company's stock worth $35,000 after acquiring an additional 55 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors. </p><h2>Insider Activity</h2><p>In related news, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares of the company's stock, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. 0.62% of the stock is owned by company insiders. </p><h2>Analyst Upgrades and Downgrades</h2><ul><li>NVIDIA’s $2B Power Play: Securing the Future of Chip Design</li></ul><p>Several research analysts have recently issued reports on SNPS shares. JPMorgan Chase &amp; Co. raised their price objective on Synopsys from $600.00 to $650.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, December 11th. The Goldman Sachs Group reduced their price target on shares of Synopsys from $700.00 to $600.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, September 10th. Rosenblatt Securities raised shares of Synopsys from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and dropped their price objective for the company from $605.00 to $560.00 in a report on Tuesday, December 9th. BNP Paribas initiated coverage on shares of Synopsys in a report on Thursday, October 2nd. They set an &#34;underperform&#34; rating and a $425.00 target price for the company. Finally, Robert W. Baird  reaffirmed a &#34;neutral&#34; rating and issued a $535.00 price target (down from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, six have assigned  a Hold rating and one  has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $562.13.</p><p><b>Get Our Latest Report on Synopsys</b></p><h2>Synopsys Trading Down 2.2%</h2><ul><li>MarketBeat Week in Review – 09/15 - 09/19</li></ul><p>Shares of Synopsys stock opened at $453.07 on Thursday. The firm has a 50-day simple moving average of $434.22 and a two-hundred day simple moving average of $504.07. The company has a market cap of $84.16 billion, a P/E ratio of 56.70, a price-to-earnings-growth ratio of 3.85 and a beta of 1.16. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. </p><p>Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating analysts' consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company's quarterly revenue was up 37.8% on a year-over-year basis. During the same period last year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS.  As a group, equities analysts predict that  Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year. </p><h2>Synopsys Company Profile</h2> (Free Report)<p>Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Synopsys</li><li>What Investors Need to Know About Upcoming IPOs</li><li>Rate Cuts Make These 3 Income ETFs More Attractive Than Ever</li><li>What is the FTSE 100 index? </li><li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li><li>What to Know About Investing in Penny Stocks</li><li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U05QUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U05QUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Synopsys Right Now?</h2><p>Before you consider Synopsys, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.</p><p>While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SNPS

<p>Tompkins Financial Corp reduced its stake in Synopsys, Inc. by 74.1% in Q3, now holding 1,966 shares valued at $970,000. Several other institutional investors adjusted their holdings, with 85.47% of Synopsys stock owned by such investors. Analysts have mixed ratings, with a consensus of 'Moderate Buy' and a target price of $562.13. Synopsys reported Q3 earnings of $2.90 per share, beating estimates, with revenue up 37.8% year-over-year.</p>

Synopsys, Inc. $SNPS Shares Sold by Tompkins Financial Corp